PRESENTATION
Q1 2026 — Earnings presentation
Q1 2026PDF · 15 pages10.0 MB
Championing a Smoke-Free World 2026 First-Quarter Results April 22, 2026 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated April 22, 2026 and on our Investor Relations website with additional non- GAAP reconciliations available at the end of this presentation 2 -- 1 of 15 -- Forward-Looking and Cautionary Statements • This presentation contains projections of future results and goals and other forward-looking statements, including statements regarding expected financial or operational performance; capital allocation plans; investment strategies; regulatory outcomes; market expectations; business plans and strategies. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by PMI • PMI's business risks include: marketing and regulatory restrictions that could reduce our competitiveness, disrupt our SFP commercialization efforts, eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; excise tax increases and discriminatory tax structures; health concerns relating to the use of tobacco and other nicotine-containing products; litigation related to tobacco and/or nicotine products and intellectual property rights; intense competition; inability to anticipate changes in adult consumer preferences; use and reliance on third-parties; the adverse effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; geopolitical instability affecting international trade; the impact and consequences of Russia's invasion of Ukraine; changes in adult smoker behavior; continued decline of tax-paid cigarettes; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; disruptions in the credit markets or changes to its credit ratings; recent and potential future tariffs imposed by the U.S. and other countries; adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for our electronic devices; and the integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful, in key markets or systemically, in its efforts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity; if there are prolonged disruptions of facilities used to produce its products; if it is unable to enter new markets or improve its margins through increased prices and productivity gains; if other market participants are more successful in their SFP commercialization efforts; if it is unable to attract and retain the best global talent; or if it is unable to successfully integrate and realize the expected benefits from recent transactions and acquisitions. Future results are also subject to the lower predictability of our smoke-free products performance • PMI is further subject to other risks detailed from time to time in its publicly filed documents, including PMI's Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2025 and the Form 10-Q for the quarter ended March 31, 2026, which will be filed in the coming days. PMI cautions that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward- looking statement that it may make from time to time, except in the normal course of its public disclosure obligations • References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., including its subsidiaries 3 Strong Growth Fundamentals, Excellent EPS Delivery • Q1 delivery ahead of our expectations with $1.96 adj. diluted EPS, +16% vs. PY • Excellent International SFP growth: ⎼ Strong IQOS progress with ~11% adjusted IMS volume growth, multicategory accretion from ZYN & VEEV ⎼ 29% gross profit growth, 19% excl. currency • Very resilient combustibles top-line and gross profit growth vs. high comparison • U.S. ZYN offtake growth of 10%; as expected a challenging financial quarter for U.S. segment on tough comparison and inventory normalization • On track for another year of best-in-class top and bottom-line growth 4 Source: PMI financials or estimates -- 2 of 15 -- Note: Organic growth rates reflect currency-neutral adj. results. Shipment volume includes cigarettes and SFPs. Source: PMI financials or estimates Q1: Very Robust Delivery Despite Timing Headwinds 5 Organic Variance Q1’26 vs. PY Shipment Volume (1.9)%184 bn Q1’26 Adj. Diluted EPS +5.3 %+16.0 %$1.96 Adj. Operating Income +0.9 %+10.0 %$4.2 bn Net Revenues +9.1 % +2.7 %$10.1 bn Adj. Gross Profit +10.1 % +3.8 %$6.9 bn Remarkable International Performance Powered by SFPs 6 Note: Organic gross margin growth is calculated from adjusted gross profit divided by adjusted net revenues. All organic metrics reflect currency-neutral adjusted results. Chart not to scale. Source: PMI financials or estimates Net Revenues Gross Profit Int’l Smoke-Free Q1’26 Organic Growth vs. PY 15.8% 19.4% +210bps to 70.0% Gross Margin Int’l Combustibles +190bps to 67.5% Gross Margin Net Revenues Gross Profit 6.4% Total International 9.7% +210bps to 68.5% Gross Margin 1.0% 3.9% +10.1% OCI +15.7% USD -- 3 of 15 -- (a) Including HTU adjusted IMS, Oral SFP and E-Vapor reported IMS. Note: Chart not to scale. Total may not foot due to rounding. Source: PMI financials or estimates Excellent SFP Volume Growth Driven by IQOS 7 Total SFP Cigarettes (shipments, equivalent bn units) 145 137 43 47 188 184 Q1'25 Q1'26 (1.9)% (5.1)% +9.1% vs. PY HTUs: +11% Oral SFPs: (16)% E-Vapor: +95% Broadly Stable ~(3)% High-SD FY Forecast SFP IMS(a) +11% Q1’26 vs. PY Q1'26 Shipment Volume Q1'26 Net Revenue Growth 9.1% Pricing (CC & Smoke-Free) Currency Sustainable Top-Line Growth Drivers 8 (a) Smoke-free mix represents the impact of the changing proportion of smoke-free products at higher net-revenue per unit. Note: Total may not foot due to rounding. Source: PMI financials or estimates (1.9)% +2.7pp +5.0pp Smoke-Free Mix (a) +6.4pp (1.3)pp Int’l CC Geo Mix & Other 2.7% Q1’26 Organic Net Revenue Growth (1.8)pp U.S. International -- 4 of 15 -- Resilient Margin Performance Underscores Strong Model 9 (a) Includes Corporate Expenses and Other (+0.1pp). Source: PMI financials or estimates Q1'25 Q1'26 Gross Profit 40.0% Currency SG&A(a) 40.7% Q1’26 Adjusted OI Margin 41.1% +0.7pp (1.4)pp +1.1pp Q1’26 (excl. currency) (70)bps +40bps (a) Including HTU adjusted IMS, Oral SFP and E-Vapor reported IMS. (b) Reflects estimated industry growth in categories where PMI is present across 108 smoke-free markets. Excl. illicit products, e-vapor open tanks. Source: PMI financials or estimates Outpacing the Industry on SFP Growth, Expansion Continues 10 3 PMI SFP Categories 2 PMI SFP Categories 1 PMI SFP Category PMI SFP Markets (#) 48 50 54 53 27 30 26 29 9 15 26 26 84 95 106 108 FY'23 FY'24 FY'25 Q1'26 PMI SFP IMS Q1’26 Growth (a) ~11% ~3pp > Industry(b) -- 5 of 15 -- 9.6% 11.4% 9.0% 12.0% 10.9% Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 IQOS: Continuing to Deliver Strong Progress 11 HTU Adj. IMS Growth (change vs. PY) Source: PMI financials or estimates 79 IQOS Markets 9.4% Excl. Japan consumer pantry loading Taiwan Third party store 12 2.9% 6.0% 6.2% 7.2% 7.3% 7.5% 9.5% 10.6% 13.5% 13.8% 14.3% 16.3% 19.7% 20.8% 23.3% 23.9% 33.9% 37.7% 40.3% Manila Tunis Riyadh Taipei Urban Jakarta Mexico City Cairo Madrid London Kuala Lumpur Seoul Munich Belgrade GTR (Airports) Prague Bucharest Rome Athens Tokyo +1.6 +1.8 PMI HTU Offtake Shares (Q1’26)(a) +3.0 Change vs. PY, pp +2.1 +2.7 +1.6 +0.8 (a) Base includes HTUs and cigarettes. (b) Based on Greater Taipei. (c) Global Travel Retail includes airports where IQOS is available, offtake share based on Dec-Feb’26 vs. Dec-Feb’25. Source: PMI financials or estimates +7.2 Excellent IQOS Progress Across Key Global Cities +0.3 +0.2 (c) +2.8 +0.6 +1.0 +2.7 +3.3 (0.2) +2.9 +2.5 (b) +3.7 -- 6 of 15 -- Multicategory Portfolio Supporting Rapid Growth 13 0.6 1.2 Q1'25 Q1'26 E-Vapor Shipments (billion equivalent units) +95% vs. PY 14.9% 19.5% 22.4% 18.4% 21.2% Q1'25 Q2'25 Q3'25 Q4'25 Closed Pods Share in Europe(a) Comp. 1 Comp. 2 VEEV Int’l Modern Oral Shipments(b) (billion pouches) 0.4 0.5 Q1'25 Q1'26 +7% vs. PY Joint #1 Brand in Europe (Q4’25, Closed Pods)(a) (a) Based on closed pods Nielsen offtake data in 19 markets (incl. UK, France, Spain, Germany, Poland, Italy) representing more than 90% of VEEV Volumes in Europe. (b) Q1’25 (0.4bn) includes only nicotine pouch shipments, Q1’26 (0.5bn) all modern oral products. +7% and +42% represents like-for-like modern oral variance. Note: ZYN includes marginal volume from other brands. See glossary for equivalent unit conversion. Source: PMI financials or estimates +42% Excl. Nordics 9.3% 8.6% 5.4% FY'24 FY'25 Q1'26 (a) Markets where characterizing flavor ban was made effective at consumer level since Jan’25, such as Hungary and Poland. (b) Q1’25 (0.3bn) includes only nicotine pouch shipments, Q1’26 (0.3bn) all modern oral products. (8)% and +31% represent like-for-like modern oral variance. Note: ZYN includes marginal volume from other brands. Chart not to scale. Source: PMI financials or estimates 14 Europe: Continued Strong SFP Growth 0.3 0.3 Q1'25 Q1'26 0.5 1.1 Q1'25 Q1'26 (8)% vs. PY +31% Excl. Nordics Shipment Volumes +107% vs. PY (billion eq. units) (billion pouches)(b) Adj. IMS Growth vs. PY +12% IQOS, ZYN & VEEV Shipment Growth Q1’26 vs. PY ~8% Excl. recent flavor ban markets(a) -- 7 of 15 -- 15 Japan: IQOS Achieves Record Share, Strong Fundamentals (a) Based on Top 3 C-Store Chains offtake, Q1’26. Base includes cigarettes, cigarillos and HTUs. Source: PMI financials or estimates 34.9% Q1’26 PMI HTU Adj. Share +2.7pp vs. PY ~53% HnB Offtake Category Share(a) 70% 69% 69% 15% 17% 18% 15% 14% 12% H1'25 H2'25 Q1'26 HnB Adj. Category Share (%) Comp. 1 PMI 8.4% 5.8% 10.4% H1'25 H2'25 Q1'26 Adj. IMS Growth vs. PY 5.9% Excl. consumer pantry loading Comp. 2 Shipments 16 (a) Based on Nielsen. (b) Estimated proxy of shipments related to consumer offtake, adjusting for wholesaler and distributor inventory fluctuations. First provided at FY25 earnings, 6 Feb 2026. Estimates by quarter for 2025: Q2’25: 180m, Q3’25: 205m, Q4’25: 200m. Note: U.S. ZYN cans contain 15 pouches. Source: PMI financials or estimates ZYN Leading U.S. Nicotine Pouch Category Despite Headwinds U.S. ZYN Volumes (million cans) ~160 ~175 Q1'25 Q1'26 +10% ZYN Q1’26 Offtake vs. PY(a) Q1’26(a) Retail Value Share: 61.3% Volume Share (cans): 55.5% • Solid growth in offtake volumes despite uneven competitive landscape • Shipment growth in line with offtake growth, excl. inventory movements: ⎼ Channel inventory now broadly normalized • Preparing to launch innovations 202 Underlying volumes(b) 155 -- 8 of 15 -- ZYN: Investing in the Brand, Navigating Regulatory Constraints 17 • Investing in brand equity • Comprehensive commercial program • Ongoing FDA review of ZYN ULTRA application, full innovation pipeline • Significant growth potential from leading premium brand Combustibles: Resilient Growth & Strong Pricing 18 (a) Pricing variance is based on adjusted net revenues. Source: PMI financials or estimates 8.9 8.7 7.6 8.5 FY'23 FY'24 FY'25 Q1'26 Combustible Pricing (% growth vs. PY)(a) 10.7% Record Q1 Marlboro Int’l Share Q1’26 Int’l Combustible Gross Profit (% organic growth vs. PY) 6.1 5.1 5.3 3.2 3.9 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 -- 9 of 15 -- (a) On an organic basis. (b) Currency neutral variance. (c) At prevailing rates. (d) At prevailing rates, subject to year-end working capital requirements. Source: PMI financials or estimates • Unchanged currency-neutral growth outlook: best-in-class growth despite transitory headwinds • Adjusted diluted EPS forecast of $8.36 - $8.51 incl. favorable currency impact of 25 cents(c) ⎼ Includes Q2 forecast of $2.02 - $2.07 with 2 cents of favorable currency (c) • Strong operating cash flow generation 19 2026 Outlook 5-7 % Net Revenues(a) 7-9 % Operating Income(a) 7.5-9.5 % Adj. Dil. EPS(b) 10.9-12.9 % Adj. Dil. EPS, USD(c) ~13.5 bn Operating Cashflow(d) 2026: Another Year of Strong Profitable Growth Expected Full Report Available Here Sustainable Value Creation: PMI Value Report 2025 • Completion of 2025 Roadmap • Introduction of Value Plan 2030+ 20 Consumers Circularity PMI Workforce Workers in Value Chain Climate Nature -- 10 of 15 -- Delivering Superior & Sustainable Growth • Q1 performance underscores strength and momentum of global smoke-free business • Supported by investment in our premium brands and the continued resilience of combustibles • Consistent, best-in-class growth • Committed to generously rewarding shareholders • Looking to full-year and beyond with confidence 21 Source: PMI financials or estimates Championing a Smoke-Free World Questions & Answers iOS Download Android Download Have you downloaded the PMI Investor Relations App? The free IR App is available to download at the Apple App Store for iOS devices and at Google Play for Android mobile devices Or go to: www.pmi.com/irapp 2026 First-Quarter Results -- 11 of 15 -- Championing a Smoke-Free World 2026 First-Quarter Results April 22, 2026 Championing a Smoke-Free World 24 Appendix and Reconciliation of Non-GAAP Measures -- 12 of 15 -- (a) Includes: $0.10 Germany excise tax classification litigation charge; ($0.10) RBH (Canada) Plan Implementation, including dividend income, net; $0.09 Impairment of Wellness business related equity investment; $0.06 Loss on expected sale of consumer accessories and other businesses; $0.03 Impairment of goodwill and other intangibles; ($0.11) Tax items. Source: PMI financials or estimates. 2026: EPS Guidance Growth 2025 2026 Forecast $7.26 $7.56 – $7.71 Reported Diluted EPS Adjustments: 0.50 0.50 - Amortization of intangibles (0.18) 0.22 - Fair value adjustment for equity security investments 0.14 0.03 - Restructuring charges (0.25) 0.05 - Income tax impact associated with Swedish Match AB financing 0.07 - - Other 2025 adjustments (a) 0.28 0.80 - Total Adjustments 10.9% – 12.9% $7.54 $8.36 – $8.51 Adjusted Diluted EPS 0.25 - Less: Currency 7.5% – 9.5% $7.54 $8.11 – $8.26 Adjusted Diluted EPS, excluding currency 25 Full-Year ($/share) Additional Market Data: Total Market and Market Share Q1’26 vs. Q1’25 26 Select Multicategory Markets (PMI present in 3 SFP categories) 2026 2025 % Change 2026 2025 pp Change 2026 2025 pp Change 2026 2025 pp Change Indonesia 63.8 61.6 3.5 29.1 30.8 (1.7) 0.7 0.5 0.2 0.6 0.4 0.2 Italy 18.1 17.8 1.2 50.7 51.1 (0.4) 20.2 18.2 2.0 19.3 17.5 1.8 Poland 11.3 13.1 (13.9) 45.1 41.7 3.4 10.9 10.0 0.9 10.0 9.2 0.8 Spain 9.7 9.9 (2.4) 28.2 28.2 - 4.0 3.4 0.6 3.7 3.3 0.4 Romania 6.2 6.9 (10.5) 24.7 21.4 3.3 14.7 10.4 4.3 11.5 9.5 2.0 Bulgaria 4.9 4.7 2.5 26.8 24.8 2.0 13.8 11.6 2.2 13.1 11.5 1.6 United Kingdom 4.5 5.8 (22.3) 12.0 9.3 2.7 5.4 3.6 1.8 4.1 3.0 1.1 Greece 3.8 3.6 6.3 49.2 47.1 2.1 30.0 26.1 3.9 27.0 25.0 2.0 Portugal 2.8 2.8 0.7 60.0 58.3 1.7 24.4 22.5 1.9 23.0 21.7 1.3 Switzerland 2.3 2.3 (1.7) 39.3 39.7 (0.4) 13.9 13.0 0.9 13.3 12.6 0.7 Total Market, bio units (a)(b) PMI Market Share, %(a)(b) Total Smoke Free Products HTU Market (a) Total market and PMI market share include cigarettes, HTUs, e-vapor (excl. open tank) and oral smokeless categories. (b) Total market and PMI IMS for Cigarettes and HTU is adjusted for the estimated impact of distributor and trade inventory movements; e-vapor and oral smokeless reflect reported total market and PMI IMS. Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%. Source: PMI financials or estimates -- 13 of 15 -- Additional Market Data: Total Market and Market Share Q1’26 vs. Q1’25 27 Select Markets - Cigarettes & HTU 2026 2025 % Change 2026 2025 pp Change 2026 2025 pp Change Russia 47.1 48.7 (3.2) 32.0 32.8 (0.8) 11.1 9.8 1.3 Turkey 36.7 35.0 4.8 48.0 49.8 (1.8) - - - Japan 36.6 35.8 2.2 45.0 43.2 1.8 34.9 32.2 2.7 Egypt 19.6 19.9 (1.9) 36.0 29.1 6.9 2.0 1.8 0.2 Brazil 18.7 20.4 (8.5) 23.5 21.9 1.6 - - - South Korea 15.8 16.1 (1.8) 20.4 20.2 0.2 10.0 9.2 0.8 Germany 15.2 15.7 (3.1) 38.7 38.4 0.3 8.4 7.7 0.7 Philippines 11.8 11.2 4.6 47.1 47.9 (0.8) 1.2 0.8 0.4 Argentina 6.6 6.8 (3.7) 63.3 63.3 - - - - Taiwan 6.3 6.4 (2.0) 11.2 6.6 4.6 5.2 - 5.2 Mexico 5.9 6.9 (13.9) 57.6 58.0 (0.4) 1.3 0.7 0.6 Market Total Market CC & HTU, bio units (a) PMI Market Share, %(a) Total HTU (a) Total market and market share estimates include cigarillos in Japan. Total market and PMI IMS for Cigarettes and HTU is adjusted for the estimated impact of distributor and trade inventory movements. Note: % change for Total Market and PMI shipments is computed based on millions of units. "-" indicates volume below 50 million units and market share below 0.1%. Source: PMI financials or estimates International Market Share 28 (a) Defined as PMI's cigarette and heated tobacco unit in-market sales volume as a percentage of total industry cigarette and heated tobacco unit sales volume, excluding China and the U.S., including cigarillos in Japan. (b) Defined as PMI's cigarette in-market sales volume as a percentage of total industry cigarette sales volume, excluding China and the U.S., including cigarillos in Japan. Note: Sum of share of market by product categories might not foot to total due to rounding. Source: PMI financials or estimates Total PMI 2026 2025 Change (pp) Cigarettes 22.6% 23.4% (0.8) HTU 6.8% 5.8% 1.0 Total International Market Share (a) 29.4% 29.2% 0.2 Cigarette over Cigarette Market Share (b) 24.8% 25.4% (0.6) First-Quarter -- 14 of 15 -- 29 PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Reconciliation of Non-GAAP Measures Reconciliation of Gross Profit by Product Category to Adjusted Gross Profit by Product Category, excluding Currency ($ in millions) / (Unaudited) (a) First-quarter 2026 and first-quarter 2025 adjusting items reflect amortization of intangibles in Smoke-free, all amounts are related to cost of goods sold. Note: Sum of product categories and adjusting items might not foot to Total PMI due to roundings. Source: PMI financials or estimates Gross Profit Adjusting Items(a) Adjusted Gross Profit Currency Adjusted Gross Profit excluding Currency Gross Profit Adjusting Items(a) Adjusted Gross Profit Total Excluding Currency 2026 Quarters Ended March 31, 2025 % Change $ 6,905 $ (6) $ 6,911 $ 397 $ 6,514 Total PMI $ 6,270 $ (5) $ 6,275 10.1% 3.8% 3,021 (6) 3,027 191 2,835 Smoke-Free 2,724 (5) 2,729 10.9% 3.9% 3,885 - 3,885 205 3,680 Combustible Tobacco 3,547 - 3,547 9.5% 3.7% Championing a Smoke-Free World 2026 First-Quarter Results April 22, 2026 -- 15 of 15 --